Bruker price target raised to $95 from $80 at Citi

Citi raised the firm’s price target on Bruker to $95 from $80 and keeps a Buy rating on the shares post the Q4 report. In a more challenged macroeconomic backdrop, Bruker has one of the better setups this year, driven by backlog insulation and margin progression with visibility on recent acquisitions, the analyst tells investors in a research note.